covid-19-disease

Documents about covid-19-disease

• Resilience of health systems in Africa to infectious disease shocks: A qualitative evidence synthesis#439663PLOS
• Determining the Safety and Efficacy of COVID-19 Vaccination in the Chronic Kidney Disease Population [CKD-COVID19, study data contributed to the CITF Databank]#657719Borealis Dataverse OAI Archive
• A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.#830913ClinicalTrials.gov
• Feuille de route de l’OMS concernant l’utilisation des vaccins contre la COVID-19 dans le contexte des variants Omicron et d’une forte immunité collective : approche visant à optimiser l’impact mondial des vaccins contre la COVID-19 alors que le variant Omicron et ses sous-lignées sont les principaux variants préoccupants en circulation, compte tenu des objectifs de santé publique, de l’évolution épidémiologique et d’une immunité collective croissante, première publication : 20 octobre 2020, mise à jour : 13 novembre 2020, mise à jour : 16 juillet 2021, mise à jour : 21 janvier 2022, mise à jour : 30 mars 2023, dernière mise à jour : 10 novembre 2023#341846WHO IRIS
• Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China#7257OpenAlex
• Accélérer la préparation et la riposte aux situations d’urgence sanitaire - plan d’action#184004WHO IRIS
• Teachers’ AI digital competencies and twenty-first century skills in the post-pandemic world#376033OpenAlex
• RSV-related hospital admissions in a subset of hospitals in England and Scotland: A real-world study (2018-2023)#642286Europe PMC
• Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France#812954ClinicalTrials.gov
• Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach to promote recovery#4557Europe PMC
• Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing#6679OpenAlex
• Principles of 3D chromosome folding and evolutionary genome reshuffling in mammals#203527SUNScholar
• Clinical and cost-effectiveness of the digital intervention, MyWay Diabetes, in people with type 2 diabetes living in Greater Manchester during the COVID-19 pandemic#313055PLOS
• Identifying the Most Important Influencing Factors Based on Demographic Information, Nutrition, Physical Activity, Leisure Time, and Underlying Diseases in the Severity of Disease in COVID-19 Patients Using Data Mining Techniques.#418624NCBI PubMed Central
• Physical Activity and Smell Trainings to Help Individuals With Coronavirus Disease (COVID-19) Recover From Persistent Smell and Taste Impairments - A Pilot Study#831841ClinicalTrials.gov
• Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)#888259ClinicalTrials.gov
• Denture-Associated Candidiasis and Mucormycosis in Post-COVID-19 Older Adults Managed Through an Integrated Prosthodontic and Infectious Disease Approach: A Narrative Review#1053226Europe PMC
• Predicting severe COVID-19 disease in adults: A single-centre cohort study during the first three pandemic waves in 2020–2021 in Vilnius, Lithuania#240427PLOS
• A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants#887754ClinicalTrials.gov
• A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19#918062ClinicalTrials.gov
• Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023–2024#1040245PLOS
• Health-related quality of life and cost-of-illness in young people seeking peer support at @ease: A Dutch burden of disease study#345364PLOS
• Influence of Both La Nina and Island Isolation During COVID-19 on the Epidemiology of Infectious Diseases in New-Caledonia#398892HAL (France)
• Factors associated with disease severity amongst children admitted with SARS-COV-2 infection in Gauteng and KwaZulu-Natal, 2020 to 2022#447680WIReDSpace
• Hoja de ruta de la OMS sobre el uso de las vacunas contra la COVID-19 en el contexto de la variante ómicron y de la elevada inmunidad de la población: criterio para optimizar el impacto mundial de las vacunas contra la covid-19 en un momento en que la variante ómicron y sus sublinajes son las variantes preocupantes dominantes en circulación, sobre la base de los objetivos de salud pública, las características epidemiológicas en evolución y la creciente inmunidad de la población, primera publicación: 20 de octubre de 2020, actualización: 13 de noviembre de 2020, actualización: 16 de julio de 2021, actualización: 21 de enero de 2022, actualización: 30 de marzo de 2023, actualización: 10 de noviembre de 2023#341849WHO IRIS
• Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1#7420OpenAlex
• The relationship between personality traits, coping styles and psychological distress among health care workers involved in the treatment and care of covid-19 patients in Kelantan Malaysia#190825USM Repository
• Impact of the COVID-19 pandemic on diagnosis, and healthcare utilization, among patients with cancer (lung, breast, and pancreas) and cardiovascular diseases (HF, AF, hypertensive, and chronic ischemic heart disease) in Germany: two systematic reviews.#220920NCBI PubMed Central
• Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care#835492ClinicalTrials.gov
• A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants#969305ClinicalTrials.gov
• Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients prescribed anticoagulants at discharge#394302Apollo
• Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection#439891S-Space: Seoul National University
• Structural physical activity restriction, cerebrovascular and diabetes mortality, and long-term care intensity in Japan: An ecological panel study across 47 prefectures (2013-2022) with a COVID-19 counterfactual analysis#478547Europe PMC
• Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis#481125OpenAlex
• Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail#895664ClinicalTrials.gov
• Observed versus estimated actual trend of COVID-19 case numbers in Cameroon: A data-driven modelling#398896HAL (France)
• The Impact of Chatbot-aid on Promoting Self-management of Men's Health in the Post COVID-19 Era#868711ClinicalTrials.gov
• A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin#875536ClinicalTrials.gov
• Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study#996341eScholarship
• Introduction of the annual report Dr Ahmed Al-Mandhari Regional Director WHO Eastern Mediterranean Region to the sixty-ninth session of the WHO Regional Committee, Cairo, Egypt, 10-13 October 2022#223734WHO IRIS
• COVID-19 vaccine effectiveness in preventing severe outcomes and assessing the impact of prior SARS-CoV-2 infection among hospitalized adults in Albania, July 2022-July 2023#174827PLOS
• Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.#683130ClinicalTrials.gov
• Temporal dynamics of SARS-CoV-2 lineages in Santa Catarina, Brasil: genomic data analysis before and during the year following the first officially reported case of Omicron#614827Figshare
• Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024#905171ClinicalTrials.gov
• Delayed intubation and 60-day mortality in severe COVID-19-associated acute respiratory failure in an emulated target trial using the OUTCOMEREA network#971121HAL (France)
• A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients#842462ClinicalTrials.gov
• Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.#854954ClinicalTrials.gov
• mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts#4586Europe PMC
• Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID)#904063ClinicalTrials.gov
• Contemporary dialogues in health sciences#928238Repositório Institucional da UFMG